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ABSTRACT  
 
BACKGROUND :   
 Periodontal infections like Chronic and Aggressive type of 
periodontitis  were found to be associated with systemic diseases.  
Studies suggested that i t  might enhance the risk for certain systemic 
diseases. Like vice,  some systemic conditions has its  effect on the 
periodontal  health.  Diabetes mellitus tend to increase  the risk for 
periodontal disease and vice versa.  Recently many researchers 
suggested the link between chronic period ontit is and anemia. The 
association of chronic periodontit is  with decreased red blood cell 
parameters suggested that this condition may be linked with Anemia of 
Chronic Disease.  Very few studies explored the effect of Aggressive 
periodontitis  on erythrocyte counts and hemoglobin levels.  This is  the 
first interventional study to investigate the hematological parameters in 
Generalized Aggressive Periodont itis patients and also evaluate  the 
effect of Non-surgical periodontal  therapy on blood parameters of 
Generalized Aggressive Periodontitis patients.  
 
AIM AND OBJECTIVE: 
 The main aim of this study is to evaluate the systemic markers 
related to Anemia in Generalized aggressive periodontitis  patients 
before and after phase I periodontal therapy.  
 
MATERIAL AND METHODS 
 A total number of 30 young adults diagnosed with Generalised 
Aggressive Periodontitis were selected for the study and after 
obtaining sign in a writ ten informed consent clinical parameters such 
as Plaque Index, Gingival bleeding index, Probing depth,  Clinical  
attachment level and Blood parameters viz.,  RBC, Hb, PCV, MCV, 
MCH, MCHC, ESR and Serum Ferri tin  levels estimation were done.  
Based on the inclusion criteria 17 patients with serum ferri tin level 
above 30ng/dl were enrolled in the study, of which two patients 
discontinued. Finally 15 patients were considered and subjected to 
phase I periodontal  therapy. At the end of three months clinical  
parameters and hematological  parameters were re -evaluated. The 
obtained results were statistically analysed using paired t- test and 
Wilcoxon signed rank test.  
 
RESULTS: 
 The Hematological parameters such as Hemoglobin and RBC 
count were found to be increased significantly after phase I therapy 
with a significant improvement in the Plaque Index score,  Gingival 
bleeding index score, reduction of Probing depth and gain in Clinical  
attachment levels.  The other blood parameters viz.,  PCV, MCV, MCH, 
MCHC values were minimally increased after  phase I therapy but the 
difference was not found to be statistically significa nt in this study. 
The ESR value also significantly decreased post -operatively.  
 
CONCLUSION: 
 Within the limitation of this present interventional study it could 
be concluded that Generalized Aggressive Periodontitis was associated 
with reduced Red blood cell parameters suggesting that it  may tend 
toward anemia of chronic disease. The treatment by Non-surgical  
periodontal  therapy not only reverses the periodontal health by 
reducing the inflammation but also improves the anemic status.  
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INTRODUCTION  
 Anemia is been defined as a decrease in the number of 
erythrocyte count or in the concentration of hemoglobin which results 
in a reduction in the oxygen carrying capacity of blood.
1  
In other terms 
it  can be defined as a “condition in which the blood is deficient either 
in quantity or in quality” The deficiency in quality may consist in 
diminution of the number of RBCs or the hemoglobin or both, it  may 
be local or due to mechanical interference with the supply of blood or 
general.  Whereas,  the deficiency in quantity or quality is due to 
imperfect  nutri tion, wasting disease or direct  loss of blood.
2  
Anemia is 
considered as a major health problem affecting both developing and 
developed countries and an indicator of poor nourishment that 
significantly affects not only the human health but also the social well -
being and economic development. Thus, i t  is an important contributing 
factor to the global burden of disease.  Most common cause of anemia is 
iron deficiency. The other possible cause could be  chronic infections, 
inflammatory conditions and micronutrient deficiency. Anemia caused 
by chronic infection or inflammation are described as Anemia of 
chronic disease (ACD) and are the second most prevalent after iron 
deficiency anemia.
3  
 
  
 Anemia of chronic disease (ACD) has been defined as the 
anemia occurring in chronic inflammatory conditions which are not due 
to marrow deficiencies or other diseases and occurring despite in the 
presence of adequate iron stores and vitamins.  
4
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 Hutter et al . ,  2001 stated that  periodontitis is  the most common 
inflammatory diseases of humans, like other chronic conditions leads 
to anemia.
5  
Periodontitis is an inflammatory disease of the supporting 
structures of the teeth which is characterized by progressive 
destruction of the periodontium init iated by chronic bacterial  
infections.
6
 Though, the tissue destruction in periodontitis is confined 
to the periodontium, the microorganisms or their products can invade 
the periodontal t issues through the ulcerated pocket e pithelium and 
gets access to reach the systemic circulation.
7  
A large number of 
studies have proved the potential  relationship between periodontal  
disease and several  systemic conditions like cardiovascular disease, 
diabetes melli tus,  adverse pregnancy out comes, obesity etc
8
.  
Researchers also have suggested that  periodontitis patients have an 
altered blood cell counts when compared with periodontally healthy 
controls.  In  an anemic state it  was conceivable that  lack of oxygen to 
the tissues acted as a modifying factor in the response of periodontium 
to local irri tat ion 
2
.  Studies have supported the hypothesis that severe 
periodontitis might lead to Anemia and also provided evidence that 
non-surgical periodontal  therapy tend to improve the status of anemia.  
  
 Various studies have correlated the presence of Anemia with 
chronic periodontit is.  Lesser document is available for inter -
relationship between anemia and aggressive periodontit is.  Aggressive 
periodontitis can be distinguished from chronic periodontit is b y the 
rapid rate of destruction, age of onset of disease,  al teration in the host  
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immune response, composition of the subgingival  microbiota, familial  
aggregation and a strong racial  influence.  
 
 Baer 1971  defined Aggressive periodontitis as a disease of th e 
periodontium occurring in an otherwise healthy adolescent that is 
characterized by rapid loss of alveolar bone about more than one tooth 
of the permanent dentition.  In the year 1989, the World Workshop in 
Clinical  Periodontics described this as localized  juvenile Periodontit is 
(LJP) and as a subset of the broad classification of early -onset 
periodontitis (EOP). Later in 1999, the World Workshop in 
Periodontics introduced a new classification system; several rapidly 
progressive periodontitis were united under the term Aggressive 
Periodontitis.
9  
It can be either localized or generalized. Localized 
Aggressive Periodontitis (LAP) is commonly seen in younger adults,  
characterized as having localized first  molar/incisors with 
interproximal attachment loss on atl east  two permanent teeth one of 
which is a first  molar. Generalized aggressive periodontitis  (GAgP) is 
been characterized as having generalized interproximal attachment loss 
that  found to be affecting atleast  three permanent teeth other than first  
molars and incisors.  
 
 Anand et al . ,  2014 suggested that  generalized aggressive 
periodontitis l ike chronic periodontitis  may be associated with risk for 
Anemia of chronic disease .
1  
Treating Aggressive Periodontit is patients 
with Non-surgical periodontal therapy has an influence in reversing the 
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anemic status.  Conventional phase I therapy consists of mechanical 
supra and subgingival tooth debridement and  self -administered oral  
health care measure instructions.  These measures help in reducing the 
bacterial load and altering the composit ion of subgingival  microflora 
that  are more beneficial to health.
1 0  
 
 Very few studies are available at present to describe the 
relationship between Anemia and Aggressive periodontit is. This 
present study is undertaken to evaluate the systemic markers related to 
anemia in the peripheral blood of Aggressive periodontitis  patients 
before and after  Non-surgical Periodontal  therapy.  
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AIM AND OBJECTIVES 
  
 The main aim of the study is to evaluate and compare the red 
blood cell parameters in Generalized Aggressive Periodontit is patients 
before and after Phase I periodontal therapy.  
 
1)  To investigate whether Generalized Aggressive Periodontitis is 
related with reduced erythrocyte count and reduced Hemoglobin 
levels,  
2)  To evaluate the effect of Non-surgical  periodontal  therapy on 
systemic markers related to Anemia in patients with Generalized 
Aggressive Periodontitis,  
3)  To compare and correlate the clinical parameters such as Plaque 
index, Gingival bleeding Index, Probing depth and Clinical  
attachment level with Hematological  parameters in Generalized 
Aggressive Periodontitis patients at baseline and after therapy.  
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GENERAL REVIEW  
ANAEMIA  
DEFINITION: “It is  a state in which the concentration of hemoglobin 
level in the blood is below the normal range for the age and gender of 
an individual”.  1 1  
 
 Determination of haematological parameters related to anaemia 
is an important way to early diagnose and treat  the disease thereby 
eliminating its further complications.  Even though the value of 
hemoglobin is the most commonly employed major parameter to 
determine whether anaemia is present or not the red cell  counts (RBC), 
Hematocrit (PCV) and blood indices (viz., MCV, MCH, and MCHC) 
also equally provide an alternative means of assessing anaemia  
1 2
.  
 
CLASSIFICATION OF ANEMIA: 
1 2  
 
 Anemia can be classified based on pathophysiologic mechanism 
and morphologic alteration of red blood cells.   
 
PATHOPHYSIOLOGIC CLASSIFICATION:  
1)  ANEMIA DUE TO INCREASED LOSS OF BLOOD  
a)  Acute post-haemorrhagic anaemia  
b)  Chronic blood loss  
2)  ANEMIA DUE TO IMPAIRED PRODUC TION OF RED BLOOD 
CELLS 
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CYTOPLASMIC MATURATION DEFECT:  
a)  Deficient haem synthesis (  iron deficiency anemia)  
b)  Deficient globin synthesis ( Thalassemic syndromes)  
 
NUCLEAR MATURATION DEFECT:  
a)  Vitamin B 12 or Folic acid deficiency  
b)  Megaloblastic anemia 
c)  Defect in stem cell proliferation and differentiation ( aplastic 
anemia, pure red cell  aplasia)  
d)  ANEMIA OF CHRONIC DISEASE 
e)  Bone marrow infil tration  
f)  Congenital  anemia  
3)  ANEMIA DUE TO INCREASED RED CELL DESTRUCTION  
a)  Haemolytic anemia  
 
MORPHOLOGIC CLASSIFICATION: 
1)  MICROCYTIC, HYPOCHROMIC 
2)  NORMOCYTIC, NORMOCHROMIC 
3)  MACROCYTIC, NORMOCHROMIC  
 
ANEMIA OF CHRONIC DISEASE:  
 Anemia of chronic disease (ACD) is a commonly occurring 
poorly understood condition that is  encountered in patients with a 
variety of diseases, parti cularly in hospital population including 
chronic infections, malignancies and rheumatological diseases. 
1 3
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 Schilling  specified that the term “Anemia of chronic disease” is  
a misnomer and it  has to be replaced with “Anemia of inflammation” 
because chronic may be misleading because changes in hemoglobin 
levels and hematocrit can occur in less than 2 weeks.  Many authors 
preferred to use the term “Anemia of chronic disease” because of the 
multifactorial and complex etiology of this disease. 
1 4
 
 
 This type of anemia is not related to bleeding, hemolysis or 
actual invasion of bone marrow, it develops secondary to an underlying 
disease process. The severity of anemia is directly related to the 
primary disease process and can be corrected only if the primary 
disease is alleviated. In general the peripheral blood picture shows 
ACD as Normocytic  and Normochromic but can have mild degree of 
microcytosis and hypochromia in long standing inflammation that  is 
unrelated to iron deficiency
 (1 1 ,  1 2 )
.  It  is  characterised by reduced serum 
iron and total  iron binding capacity but iron stores are normal or 
increased as indicated by the serum ferritin or prusian blue stain for 
marrow iron. 
1 5
 
 
 Conditions that commonly associated with ACD are acute /  
chronic infections,  autoimmune disorders,  chronic kidney diseases 
(CKD) and chronic inflammatory conditions.  
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 The prevalence range of ACD caused due to chronic 
inflammation is 23-50%, thus it was also termed as “Anemia of 
inflammation” (AoI).  1 3  
 
Cartwright postulated that three pathologic processes found to be 
involved in the etiology of ACD: 
1 5  
1)  Shortened or decreased survival of Erythrocyte  
2)  Failure of bone marrow in the increased production of RBC to 
compensate for increased demand ( defective RBC producti on) 
3)  Impaired release of iron from the reticuloendothelial system.  
 
 The other different pathways that  have been presumed to cause 
ACD are aversion of iron traffic, reduced erythropoiesis, decreased 
response to erythropoietin,  erythophagocytosis and invasio n of bone 
marrow by tumour cells and pathogens.
1 3  
 
ANEMIA SECONDARY TO CHRONIC SYSTEMIC DISORDERS:
1 2  
The possible causes of anemia of chronic disease are as follows.,  
1)  Anemia of chronic inflammation or infection:  
a)  Infections e.g. Tuberculosis, lung abscess, pneumonia,  
osteomyelitis, subacute bacterial endocarditis,  pyelonephritis .  
b)  Non-infectious inflammations e.g. autoimmune diseases like 
Rheumatoid arthri tis, systemic lupus erythematosis,  
vasculitis, dermatomyositi s, scleroderma, sarcoidosis, crohn’s  
disease.  
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2)  Anemia of renal disease:  
 Uraemia, Renal failure.  
3)  Anemia of hypometabolic state:  
 Protein malnutrition, Scurvy, Pregnancy, Liver disease,  
 Endocrinopathies etc.  
 
PATHOPHYSIOLOGY: 
 The etiology of ACD is categorized by an activation of immune 
cell and response of inflammatory cytokine that  blunts erythropoietin 
production, decreases erythropoiesis, impaired red cell life span and 
dysregulated iron homeostasis  
1 3
.   
 
1.  DEFECTIVE RED CELL PRODUCTION:  
 Even though there is abundance of storage iron (serum ferritin) 
but the amount of iron in developing erythroid cells in the marrow is 
below normal. This is because of the mononuclear phagocyte system is 
hyperplastic and also traps all the available free iron due to 
hyperactivity of iron binding protein Lactoferrin.  A defective transfer 
of iron from macrophages to the developing erythroid cells in the 
marrow leads to decreased availability of iron for haem synthesis 
despite of adequate iron stores,  elevati ng serum ferritin levels. The 
defect  lies in suppression by cytokines at some stage in erythropoiesis 
for e.g TNF, IFN-β released in bacterial  infections and tumours, IL -1, 
IFN-γ released in patients of rheumatoid arthritis and autoimmune 
vasculitis.  
1 2
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2.  ALTERED EPO (ERYTHROPOIETIN) METABOLISM:  
 Erythropoietin is  the primary hormone that  is  responsible for the 
regulation of erythropoiesis,  in case of ACD it is inversely related with 
the haemoglobin. As Hb decreases EPO increases. Since it  has a major 
role in erythropoiesis EPO has been a focus of investigation in ACD. 
Anemia associated with rheumatoid arthritis is  the best example of 
ACD, investigation of EPO levels in ACD were performed in patients 
suffering from Rheumatoid arthritis.  Increased serum EPO in response 
to the development of anemia was seen. Although these patients had 
increased serum EPO levels in response to development of anemia, the 
EPO levels were lower in anemic patients without rheumatoid arthritis.  
Decrease in the incremental response of EPO to anemia may be the 
cause of reduced erythropiesis in ACD but i t  cannot be taken into 
consideration as a primary cause because EPO levels are sti ll  seen to 
be higher in persons without anemia. Thus, the defective marrow 
response to these increases in EPO must be considered as the primary 
reason for the anemia.
1 5  
 
DECREASED EPO SYNTHESIS:  EPO release in response to anemia is 
said to be blunted in patients with Anemia of Inflammation (AoI). This 
may be the result of the action of several cytokines.  
 
IMPAIRED EPO ACTION: Decreased response of the erythroid 
precursors to EPO, this unresponsiveness may be the result of 
macrophage- derived factors.  
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3.  DECREASED RBC SURVIVAL: (1 2 ,  1 4 )  
 The l ife span of RBC is reduced to 60 -90 days compared to the 
normal 90-120 days;  it  is mainly because of the role of macrophages in 
RBC disposal.  Macrophage normal function is to remove senescent 
RBCs from the circulation; therefore it  is possible that  macrophages 
activated by the inflammatory process will exaggerate this regular 
function. Senescent RBCs and those coated by Igs or immune 
complexes are released efficiently by an activated phagocytic system.  
 
ROLE OF SPECIFIC CYTOKINES IN THE ETIOPATHOGENESIS 
OF ACD:
 
 CYTOKINES such as Interleukin-1 (IL-1), Interleukin-6 (IL-6),  
Tumour necrosis factor - α (TNF-α), and interferons were hypothesized 
to be involved in the maintenance of RBC production or stability.
1 6  
Means and krantz stated that  cytokines involved in the in flammatory 
response are found to be increased in the diseases associated with 
ACD. TNF-α plays a significant role in inflammatory and immune 
response. Administration of TNF to animals resulted in the 
development of anemia but no decrease in platelets or gr anulocyte 
counts were seen. Interleukin 6 (IL-6) is a pluripotent cytokine with 
pro-inflammatory, hematopoietic and immunomodulatory  effects  
Atkins et al, 1995 
1 7
.  Anemia associated with administration of rhIL-6 
was rapid in onset , progressive and dose -dependent and the condition 
reversed quickly after cessation of the rhIL-6 therapy. IL-1 is a 
polypeptide that has a wide variety of actions in inflammation and 
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immunity and shares properties of TNF. IL-1 levels are elevated in 
Rheumatoid arthrit is  patients, this correlates with markers  of disease 
activity such as anemia. γIFN  is  produced mainly by T- lymphocytes  
and is involved in the modulation of immune and inflammatory 
response as well as the host defence against microbial  challenge. 
Increased levels of γ IFN seen in patients with autoimmune and 
infectious disease.  Most of the cytokines involved in inflammatory and 
immune response inhibit erythroid colony formation in vitr o or are 
associated with development of anemia including α and β IFNs, IL -6,  
TNF β and may merit investigation for a role in etiology of ACD. 1 5  
 
HEPCIDIN –  HALLMARK IN ACD:1 3  
 Change in the pattern of iron distribution is initiated by 
inflammatory cytokines. ACD patients  are found to have low serum 
iron, low or normal iron binding capacity,  low transferrin saturation 
and low reticulocyte counts.  An accumulation of iron in the 
reticuloendothelial  macrophages despite of decreased circulating iron 
levels is  the primary feature of ACD. Thus, reduced serum iron leads to 
reduced haemoglobin synthesis inspite of adequate iron storage. 
Recently researchers stated that Hepcidin has a functional role in iron 
deficiency present in ACD. Weinstein et al.,  2002
1 6  
Hepcidin is  a 
peptide hormone, produced in the liver and detectable in serum and 
urine.  It has intrinsic antimicrobial activity and a response to 
inflammatory st imuli the expression of Hepcidin is  increased. It  is  a 
negative regulator of Iron absorption in  intestine and macrophage 
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associated iron release. Interleukin 6 acts on the hepatocytes and 
induces the release of Hepcidin.
1 3  
 
 Hepcidin found to act by compounding and initiating the 
degradation of Ferroportin,  which is the only known Iron exporter that  
is present on the surface of hepatocytes,  duodenal enterocytes and 
macrophages thus it  is one of the important transporters of cellular 
iron. Depletion of Ferroportin would stop the transfer of cellular iron 
into the plasma. Increased serum Hepcidin level s reduce the intestinal 
iron absorption and inhibit  the export of iron from tissue storage into 
the blood stream. In contrast , the l imited levels of iron  in the 
circulation down regulates the synthesis of hepcidin, this allows an 
influx of bioavailable form of iron from duodenal enterocytes and 
tissue iron stores.  Inflammation caused by infection, autoimmune 
disease and oral cancers stimulates the synthesis of pro -inflammatory 
cytokines such as INF, IL-1 and 1L-6 and these cytokines tend to 
induce the expression of excess Hepcidin, this has the ability to impair 
the function of ferroportin on duodenal enterocytes and macrophages 
that in turn impaired the absorption of iron from the gut and 
exaggerated iron retention. This mechanism of long term release of 
Hepcidin that causes ACD is said to be a Hall mark of ACD.  
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MECHA NIS M OF  A CTIO N : 1 8  In  ca s e  o f  i n f lam mator y d i s eas e ,  c yt ok in es  r e l ea sed  b y t h e  
ac t i va t i on  of  l eu k oc yt es  an d  o th e r  c e l l s  ex e r t  mu l t i p le  e f f ec t s  t h a t  l ead  t o  t h e  d ec r eas e  i n  t h e  l ev el  
o f  h a em og lob in .   
( A)  In d u c t i on  o f  h ep c id in  syn th es i s  i n  t h e  l i v er  esp ec i a l l y  b y In t e r l eu k in -6  IL-6 ,  h ep c i d in e  
b in d s  t o  fer rop or t i n ,  t h e  p or e  t h a t  a l l o ws  eg r ess  o f  i ron  f r om r e t i cu lo en d oth e l i a l  
mac rop h ag es  an d  f r om  in t es t i n a l  ep i t h e l i a l  c e l l s .  Th i s  b in d in g  of  h ep c id in  t o  f e r r op o r t i n  
l ead s  t o  d ep l e t i on  o f  f e r r op o r t i n ;  t h e  cor r e sp on d in g  seq u es t ra t i on  o f  i r on  i n  t h e  
mac rop h ag e r ed u ces  t h e  ava i lab i l i t y  o f  i r on  t o  er y th r o id  p recu rs ors .  
(B)  In h ib i t i on  of  e r y th r op oi e t i n  re l ea s e  f r om th e  k id n ey esp ec i a l l y  b y In t er l eu k in  1 β  ( IL - 1 β)  
an d  TN F α ,  r ed u ces  t h e  er y th ro p oie t i n - s t imu la t ed  h ema t op oie t i c  p r o l i f e ra t i on .  
(C)  Dir ec t  i n h ib i t i on  of  t h e  p r o l i f era t i on  o f  e r yth ro id  p r o g en i tors  esp ec i a l l y  b y  TN F  α ,  
In t e r f e ron -γ  [ IN Fγ ]  an d  IL - 1 β .  
(D )  Au gm en ta t i on  o f  e r y th r op h agoc yt os i sb yr e t i cu lo en d oth e l i a l  mac r op h ag es .  
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HAEMATOLOGICAL DIFFERENCE BETWEEN IRON 
DEFICIENCY ANEMIA AND ACD:
1 3  
 The indicator of serum iron stores are the levels of Transferrin. 
Initially it  was called Siderophilin later; Holmberg and Laurell  named 
it Transferrin. In Iron deficiency anemia Transferrin is found to be 
increased whereas Transferrin saturation  is reduced. In ACD transferrin  
levels may remain normal or reduced. Transferrin  saturation is reduced 
in ACD as well as in iron deficiency.  
 
 Ferritin is an acute phase reactant that  is usually incre ased in  
chronic inflammation, autoimmune disorders, chronic infection and 
chronic l iver diseases. It  also plays a vital role in storage of iron and 
recycling. Ferritin molecule can store up to 4,500 iron atoms. The 
increase in the synthesis of ferritin dur ing inflammation is because of 
the influence of IL-1 and TNF. Cytokines indirectly initiates ferritin 
synthesis by increasing the uptake of iron by Hepatocytes.  Besides 
being an iron storage protein it also plays a critical role in 
macrophages where it recycles iron from old RBCs and transfers it  to 
apoferritin.  The iron present in transferrin  is transported to immature 
RBCs in the bone marrow to complete the cycle.   
 
 A level of 15ng/ml of ferrit in is  generally indicative of absent 
iron stores. A predictive value of iron deficiency is reflected with 
ferritin levels 30ng/ml. In ACD, ferrit in is increased due to immune 
activation along with increased storage and retention of iron within the 
reticuloendothelial  system.  The levels of soluble Transferrin recepto r 
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is increased in iron deficiency even though the availability of iron for 
erythropoiesis is less. In contrast , the levels of soluble transferrin 
receptors in ACD are not affected because the inflammatory cytokines 
have a least impact on transferrin recept or expression. Soluble 
transferrin receptors evaluation is helpful in differentiating ACD 
patients and patients accompanied with both ACD and iron deficiency. 
The concentration ratio of soluble transferrin receptors to the log of 
ferritin levels may be useful in differentiating iron deficiency from 
ACD. A ratio of< 1 suggests ACD, whereas ratio more than 2 is an 
indicative of absolute iron deficiency co -existing with ACD.  
 
Serum levels that differentiate Anemia of chronic disease from 
iron-deficiency anemia. (Guenterweiss 2005) 
3  
VARIABLE 
ANEMIA OF 
CHRONIC 
DISEASE 
IRON 
DEFICIENCY 
ANEMIA 
BOTH 
CONDITIONS 
Iron Reduced Reduced Reduced 
Transferring 
Reduced to 
normal  
Increased Reduced 
Transferring 
saturation 
ferritin  
Reduced Reduced Reduced 
Ferritin  
Normal or 
increased 
Reduced 
Reduced to 
normal 
Soluble 
transferring 
receptor 
Normal Increased 
Normal to 
increased 
Ratio of soluble 
transferring 
receptor to log 
ferritin  
Low (less than 
1) 
High (greater 
than 2) 
High (>2) 
Cytokine levels  Increased Normal Increased 
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MANAGEMENT OF ACD:
1 3  
 The development of anemia  would even more worsen the 
underlying chronic diseases. It  is referred as a predictor of poor 
prognosis of that particular disease.  An ideal treatment option for ACD 
is to eliminate/ reduce the underlying chronic disease process.   
 
 Therapeutic management  of ACD includes increasing 
Hemoglobin levels by administration of Iron or blood transfusion. 
However,  it  is  based on the underlying systemic disease.  Newer trend 
of administrating erythropoietin stimulating agents are available.   
 
Gunter Weiss et al. ,  2005 
Treatment  
Anemia of 
chronic disease  
Anemia of 
chronic disease 
with iron 
deficiency 
Treatment of 
underlying 
disease 
Yes Yes 
Transfusion Yes Yes 
Iron supplements  No Yes 
Erythropoietic 
agent  
Yes 
Yes (patients who 
do not respond to 
iron therapy)  
 
 The other common therapies includes oral iron supplements that  
are easily available and of low cost but their effectiveness is 
questionable because of Hepcidin  mediated iron block in the intestine 
that  hinders absorption of iron, hence intravenous therapy can be 
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indicated. It is well known that IL-6 promotes the Hepcidin production, 
hence administration of IL-6 inhibitors like anti  IL-6R antibody 
therapy have known to inhibit  Hepcidin levels, decrease C -reactive 
protein levels within 1 week and also improvement  in the 
hematological parameters over a period of 4 weeks after therapy was 
seen. But the administration of these newer agents such as cytokine 
inhibitors, anti -tumour necrosis factor are stil l  under research and are 
not actively found to be prescribed in majority of population.  
 
 Ryan et al.,
1 8  
Red blood cell  transfusions are found to be 
beneficial in patients with more severe anemia and are appeared to be 
harmful in patients with mild to moderate anemia. Transfusion in 
patients with anemia was found to be associated with increased risk 
and mortality.  Thus, anemia of chronic disease when untreated is 
harmful but the available intervention that increases the level of 
hemoglobin confers even greater harm. So it  is  better to treat  the 
underlying cause of the disease than to treat  the disease itself.  If  the 
primary cause is  been eliminated a better improvement from the disease 
will be achieved. In case of ACD, treatment of underlying chronic 
disease should be the first attempt to be carried out i n order to manage 
such complex diseases.  
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PERIODONTITIS - AN INFLAMMATORY DISEASE:
1 9  
 Periodontitis is  an inflammatory disease of the tooth supporting 
structures.  It  is  broadly classified into 2 types Chronic and Aggressive 
Periodontitis. Chronic  Periodontitis  is commonly seen in adults 
whereas Aggressive  Periodontitis  is usually seen in young otherwise 
systemically healthy individuals.  The characteristic feature of 
aggressive periodontitis is  its rapidly progressive nature.  
 
 Periodontal infection  not only causes a loss of tooth support , i t  is  
also considered as a risk factor for systemic conditions that  includes 
rheumatoid arthritis,  respiratory disorders, cardiovascular diseases and 
diabetes mellitus.  A low grade inflammatory burden was suspected  as a 
possible mechanism that  has linking relationship between periodontitis  
and systemic disease. Infected and inflamed periodontal tissues act  as a 
source of periodontal pathogens, virulence factors and inflammatory 
mediators that spread into circulation , creating and sustaining a 
chronic systemic inflammatory burden. Low grade inflammation 
causing slight elevation of the levels of inflammatory markers is 
recognised as an important mechanism in the pathogenesis of systemic 
diseases including metabolic syndrome, insulin resistance and Cardio 
vascular diseases (i.e atherosclerosis, acute myocardial infarction and 
stroke).   
 
 Tumor necrosis factor –  alpha (TNF-α) is a pro -inflammatory 
mediator that  initiates the production of collagenases, prostaglandins, 
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chemo and cytokines, cellular adhesion molecules and factors related 
to bone resorption. IL-17 is a pro-inflammatory cytokine that is 
produced by cluster of differentiation 4+ (CD4+) T -cell  subset termed 
T-helper (Th) 17, that rapidly promotes recruitment of neutrophils, and 
also stimulates other cells to produce pro -inflammatory mediators such 
as IL-1β and -6, TNF-α and an acute phase reactant C -reactive protein 
(CRP) that is related to vascular inflammation. Elevated levels of 
circulating TNF-α, IL-6 and -17 and CRP have been related to an 
increased risk for cardiovascular events and other systemic diseases.   
 
 Severe periodontitis  has been associated with increased serum 
levels of TNF-α, IL-6, IL-1β and CRP, thus a role for periodontal 
diseases as a potential  risk that  contributes to general  inflammation 
and development of systemic disease was suggested. Interventional 
studies also hypothesized that  treating periodontal  disease could result  
in decreasing the circulating levels of pro -inflammatory mediators.   
 
 Duarte et al. ,  conducted a pilot  study and evaluated the serum 
levels of TNF-α, INF-γ; and IL-4,  -17 and -23 before and after phase I 
periodontal  therapy in Aggressive periodontitis,  chronic periodontitis  
and control  group. Subjects with GAgP  had a higher circulating levels 
of TNF-α, IL1 than subjects with chronic periodontitis  and healthy 
controls, although clinical periodontal condition and serum levels of 
cytokines were improved significantly as a result  of periodontal 
therapy.  
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 Periodontium can be stated as a cytokine reservoir, the pro -
inflammatory cytokines TNF-α, IL-1β, and gamma Interferon as well  as 
Prostaglandin E2  (PGE2) reach the tissue in higher concentration in 
periodontitis condition.
7
The subgingival  microbiota in periodontitis  
patients provides a persistent Gram -negative bacterial challenge to the 
host that would be met by a potent immunomodulatory response. The 
endotoxins and LPS released by these organisms have a ready access to 
tissues and to the circulation via sulcular  epithelium that is frequently 
ulcerated. By this given mechanism the periodontal infection can have 
an impact on systemic health, the diseases and conditions possibly 
influenced by periodontal infection are cardiovascular diseases, 
diabetes, adverse pregnancy outcomes, and respiratory diseases.  One of 
the major mechanism by which Anemia of Chronic Disease (ACD) 
develops is the increased production of cytokines. The increased 
production of cytokines tends to depress erythropoietin producti on 
leading to development of anemia. Lainson et al. ,  and Chawla et al.,  
suggested Anemia as a cause or pathogenesis of periodontal diseases.   
 
 Later in 1935 Epstein  first put forward the concept that Anemia 
is secondary to periodontitis
 2 0
.   
 
 William’s RC, Offenbacher S et al.,2000  described periodontal  
medicine as a rapidly emerging branch of Periodontology focussing on 
establishing a strong relationship between periodontal disease and 
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systemic health and offers new insights of the oral cavity as one system 
interconnecting with the whole human body.  
 
 Studies in the past done to clarify association between 
periodontal  disease and decreased red cell  parameters were either 
cross-sectional or longitudinal and described the co -existence of 
chronic periodontitis  and anemia . This is  the first  interventional study 
carried out to discover the effect of SRP in the improvement of 
Hematological parameter in Generalized Aggressive Periodontitis  
patients.  
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REVIEW OF LITERATURE 
 
Cash JM et al .,  1989 
2 1 
 Conducted a prospective study and hypothesized that many 
patients have anemia with the characteristics of ACD (Anemia of  
Chronic Periodontit is) but do not have any of the infections, 
inflammatory or neoplastic disorders usually associated with ACD, 
therefore evaluated a series of anaemic patients admitted to county 
hospital . 7 patients with iron deficiency were not considered, 90 with 
ACD were compared with 75 non-ACD patients. Anemia in ACD 
patients was found to be severe,  the mean hematocrit value was 31% 
and 20% of patients had hematocrit values below 25%. The serum iron -
binding capacity was quite lower in ACD and found to be normal in 
non-ACD patients.  This study pointed out the nosological  and 
terminological problems in ACD and stated that anemia may occur in 
infectious, inflammatory and neoplastic diseases for a variety of other 
reasons such as bleeding, hemolysis or marrow involvement and also 
included that patients might have anemia and the abno rmalities of iron 
distribution characteristic of ACD but lack one of the traditional 
“chronic diseases”. The abnormality in the distribution of iron may not 
be present in patient with iron deficiency, thus it was anticipated that  
further insight into mechanisms would lead to a better definition of 
ACD and concluded that unti l a proper etiologic and pathogenetic 
mechanisms were understood, a broad inclusive view about ACD seem 
to be prudent.  
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Greenstein G 1992 
2 2  
 Presented a literature review in order to cla rify the potential  for 
successful  treatment of patients with periodontitis using mechanical 
non-surgical  therapy. Clinical,  microbiological  and histologic 
responses to phase I therapy were evaluated to provide guidelines for 
expected treatment outcomes.  Clinical trials were demonstrated that  
non-surgical therapy was sufficient enough to resolve inflammation and 
arrest  periodontitis  and concluded that  most patients with mild to 
moderate periodontitis can be successfully treated with non -surgical 
therapy.  
 
Loos G et al .,  2000 
2 3  
 The purpose of this study was to investigate systemic levels of 
inflammatory markers of cardiovascular diseases in patients with 
destructive periodontal disease in comparison with periodontally 
healthy individuals.  Plasma C- reactive proteins and IL-6 were 
measured particularly and total leukocyte and differential leukocyte 
counts measurements were also performed. CRP levels and IL -6 levels 
were higher in generalized periodontitis and localized periodontitis  
when compared to healthy controls.  Leukocytes were also elevated in 
generalized periodontitis compared to localized periodontitis and 
controls.  Result  of this study concluded that  periodontitis  results in 
higher systemic levels of CRP, IL-6 and neutrophils.  
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Hutter JW et al.,  2001 
5  
 Aimed to evaluate the signs of Anemia in patients with 
Periodontitis. 39 patients with severe periodontit is, 71 with moderate 
periodontitis  and 42 healthy controls were participated in this study. 
Several  hematological  parameters were determined from pe ripheral 
blood samples. The results indicated that periodontitis patients had a 
lower hematocrit, hemoglobin and erythrocyte counts but higher ESR 
value proving that  periodontitis patients may have many systemic 
problems.  
 
Christan C et al .,2002
 2 4  
 The purpose of the study was to examine the systemic effect of 
non-surgical  therapy on white blood cell  count and differential  blood 
count in smoking and non-smoking generalized aggressive periodontitis  
patients. Total number of 27 adult  patients with previousl y untreated 
generalised aggressive periodontit is  were recruited of which 13 
smokers and 14 non-smokers were segregated. Periodontal 
examinations were performed at baseline and at  the end of third month 
after subgingival therapy. Periodontal parameters like  pocket Probing 
depth and Relative attachment level were recorded. Venous blood 
samples were taken to analyse WBC counts and differential blood 
counts.  Clinical and demographic differences were not found between 
smokers and non-smokers, following non-surgical  therapy a reduction 
in the WBC, neutrophil  and platelet counts were seen in non -smokers 
while smokers’ platelet  counts were only reduced. Non -smokers had a 
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significant higher reduction of WBC counts and neutrophils than 
smokers. Thus, study concluded t hat  a therapeutical intervention might 
have a systemic effect on the blood count in generalized aggressive 
periodontitis patients.  
 
Loos G et al .,  2005 
2 5  
 Reviewed and summarized the knowledge on systemic levels of 
systemic markers of inflammation in peri odontitis.  From peripheral  
blood sample cellular factors viz . , WBCs, RBCs, and thrombocytes 
were discussed, furthermore plasma levels of acute -phase proteins, 
cytokines and coagulation factors were reviewed. From the available 
literature the information reviewed were total  Number of leukocytes 
and plasma CRP levels and the levels were higher in patients with 
periodontitis than controls. The erythrocyte and haemoglobin levels 
were lower in periodontitis patients and stated that  it  tends towards 
ACD. The systemic markers of inflammation discussed in the review 
were also regarded as markers for cardiovascular disease.  
 
Havemose –  Poulsen et al. ,  2006  2 6  
 Aimed to elucidate whether patients with Localized Aggressive 
Periodontitis (LAP), Generalized Aggressive  Periodontitis (GAP) and 
Juvenile Idiopathic Arthritis (JIA) and Rheumatoid Arthritis(RA) share 
clinical and blood parameters distinguishing them from subjects free of 
diseases. All subjects underwent a standardized interview, blood 
sampling and an intraoral  examination, clinical parameter like plaque 
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index, bleeding on probing, probing depth, clinical attachment level 
and alveolar bone loss on radiograph were recorded. Hematological 
parameters like erythrocyte fraction, leukocyte and differential counts, 
ESR, CRP, immunoglobulin IgM and IgA rheumatoid factors (RFs) and 
antibodies to cyclic citrulinated peptides were included. The findings 
concluded that young adults with RA might develop periodontal  
destruction and these patients require attention. GAP pati ents may 
present with elevated levels of traditional markers of inflammation 
similar to patients with RA and JIA. Thus, similarities in periodontal  
and blood variables were found in individuals with GAgP, JIP and RA, 
distinguishing them from controls.  
 
Erdemir et al. ,  2008
 2 7  
 Investigated the effect of cigarette smoking on clinical 
parameters and signs of ACD in Chronic Periodontitis (CP) patients. 88 
patients with CP including 45 smokers with age group of 30 -69 years 
and 43 non-smoking volunteers with age range of 32-61 years were 
enrolled in the study. The findings resulted in higher PI,  PD and CAL 
score in smokers than non-smokers (p<.05) and number of erythrocytes 
and levels of hemoglobin,  Hematocrit and iron were found to be lower 
in smokers compared to non-smokers. Thus, concluded that  cigarette 
smoking may be effective in the signs of anemia of chronic disease in 
patients with chronic periodontitis .  
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Shi D et al. ,  2008 
2 8  
 The study aimed to explore the characterist ics of peripheral 
blood cellular  and serum protein parameters in individuals with 
Aggressive periodontitis.  150 aggressive periodontitis  and 94 healthy 
control were recruited, clinical parameters viz .,  PD, CAL and blood 
variables such as leukocyte, neutrophil and lymphocyte counts as wel l  
as serum protein including total  protein, albumin, globulin, 
albumin/globulin ratio were analysed. The results indicated elevated 
peripheral leukocyte numbers and serum globulin levels and decreased 
serum albumin and albumin/globlin ratios compared to co ntrols.  
 
Agarwal N et al. ,  2009 
4  
 Carried out an interventional study to evaluate Periodontitis  as 
one of the etiological  factors leading to ACD. 30 chronic generalized 
periodontitis male patients with Hb below 15mg/dl and serum ferritin 
above 30ng/ml were selected, various blood parameters (RBC count,  
ESR, MCV, MCH & MCHC) and periodontal  parameters (PI,  GI,  PD & 
CAL) were recorded at baseline and after periodontal therapy same 
parameters were recorded at the end of 3
rd
 month and 1 year. The result  
showed that correction of periodontal inflammation lead to a 
significant increase in haemoglobin concentration and erythrocyte 
counts.  The ESR value was decreased indicating resolution of 
inflammation and lesser improvement was found with the blood 
indices. Thus, evidence concluded that treatment of periodontitis leads 
to an improvement in hematocrit and other related blood parameters in 
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chronic generalized periodontitis  patients with anaemia, suggesting 
that  periodontitis like other chronic diseases might cau se anaemia.  
 
Alijohani A et al. ,  2009 
2 9  
 Aimed to investigate the association between hemoglobin level 
and the severity of chronic periodontit is. Data collection from 124 
systemically healthy chronic periodontitis patients were done. 
Periodontal parameters l ike bleeding on probing, probing depth,  
clinical  at tachment loss,  mobility,  missing teeth were recorded. Blood 
samples were collected for assessing hemoglobin concentration. The 
result  of the study suggested that  there were no significant corre lation 
found between hemoglobin and the means of clinical attachment loss 
and bleeding on probing and also stated that there was no association 
between hemoglobin levels and periodontal status.  
 
Duarte PM et al .,  2010 
1 9
  
 This pilot  study aimed to evaluat e the serum levels of tumour 
necrosis factor- alpha (TNF-α) and interleukin IL-4, 17 and 23 in 
subjects with generalized chronic periodontitis  (CGP) and generalized 
aggressive periodontitis  (GAgP) before and after non -surgical  
periodontal  therapy. The resu lts after periodontal  therapy in both group 
demonstrated a significant improvement in clinical periodontal status. 
At baseline, the concentration of TNF-α and IL-17 were higher in 
GAgP group compared to the other groups and a significant decrease in 
serum concentration of TNF-α and IL-17 after therapy in GAgP was 
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seen. It  has been concluded that  GAgP group has a higher levels of 
TNF-α and IL-17 than subjects with chronic generalized periodontitis  
and controls.  
 
Gokhale SR et al .,  2010 
3 0  
 Aimed to probe the association between chronic periodontitis and 
anaemia. Evaluated the peripheral  blood samples for red blood cell 
parameters and compared it  in male patients with chronic periodontit is  
patients and healthy controls. A total  number of 60 systemically 
healthy male patients with mean age group of 38 years were enrolled of 
which 30 healthy controls and 30 severe periodontitis patients were 
assessed. The result  showed that patients suffering from CP had a 
lower number of RBCs and Hb than controls, thus it was co ncluded that 
like other chronic condition, CP lead to anemia.  
 
Shin-Yu Lu et al .,  2010 
3 1  
 Presented a case report  of severe anemia caused by severe 
periodontitis  in a 50 years old female.  Patient had a complaint  of 
general weakness and looked debilitated.  Hematological parameters 
revealed increased WBCs and decreased RBCs. Dental condition was 
poor and diagnosed as severe periodontitis. After dental  treatment 
(extraction of hopeless teeth, oral  prophylaxis and delivering new 
dentures)  anemic state was reversed to health and improved the quality 
of l ife.  
 
Review of Literature 
 
32 
 
Naik V et al. ,  2010 
3 2  
 Conducted a case-control study to evaluate the levels of systemic 
haematological markers indicative of anemia in patients with 
generalized severe chronic periodontitis.  30 systemically healthy urban 
male patients divided into 2 groups based on periodontal  status as  
group A (n=15) with generalized, severe chronic periodontitis  and 
group B patients with clinically healthy periodontium as control group 
(n=15).  Blood samples were collected for investigating hemoglobin,  
total  number of red blood cells, hematocrit/PCV, ESR and blood 
indices. The results concluded that the mean values of hemoglobin, 
RBCs, PCV and ESR were higher in group A than group B indicating 
link between severe  periodontal disease and anemic status.  
 
Pradeep AR et al .,  2011 
3 3  
 Investigated whether chronic periodontitis patients have anemic 
status and analysed the effect of phase I therapy after 6 months. A total  
of 187 chronic generalized periodontitis subjects  were made to 
participate, 60 individuals with reduced red cell parameters entered 
into second part of the study in which they were treated with non -
surgical  therapy, clinical  and blood parameters were repeated at 3 and 
6 month. The results suggested that stat istical improvements were seen 
after phase  I therapy over a six month period. Thus, it  strengthens the 
hypothesis that  chronic periodontitis may lead to anemia and provided 
evidence that non-surgical  periodontal  therapy could improve the 
anaemic status in individuals with chronic periodontitis .  
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Yamamoto T et al .,  2011 
3 4  
 The study utilized longitudinal data from health checkups to 
clarify the relationship between periodontal disease progression and 
changes in the erythrocyte parameter in 120 subjects (35 men and 85 
women from Japanese population). Comprehensive screening and 
dental  checkups were done, progression group comprised 30 subjects 
and had observed changes in the erythrocyte counts compared with 
non-progression group. Hence, suggested that pro gression of 
periodontal  disease is associated with a decrease in erythrocyte count 
in rural  Japanese population.  
 
Garg B et al. ,  2012 
3 5  
 Undertaken this study to assess routine hematological parameters 
and body iron stores of blood donors to identify whether they were 
potentially prone to develop iron deficiency anemia in 116 male 
donors, Pre-donation Hb, Hemogram and serum ferritin investi gations 
were done and allocated into 2 groups based on the number of 
donations.  Findings suggested that first time donors had higher mean 
serum ferritin than repeated donors, recommending iron supplements 
for adequate period post donation.  
 
Malhotra R et al. ,  2012 
8  
 Evaluated the effect of chronic periodontal disease on 
erythrocyte count, Hemoglobulin and Hematocrit(HCT) and assessed 
the changes produced in these parameters after the provision of 
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periodontal  therapy in 40 systemically healthy subjects in the age 
group of 25-50 years. Subjects were allocated into two groups as group 
A with chronic generalised gingivitis  and group B with chronic 
generalised periodontitis  on the basis of cl inical find ings.  After 
performing complete oral prophylaxis patients were adviced to report  
after 3 weeks and 3 months, blood and clinical parameters were re -
evaluated to analyse the difference after phase I therapy. The obtained 
results showed that  the mean values o f RBC count, Hb, and HCT were 
lower in group B than group A and a significant increase at the end of 
3 months in group B was observed.  
 
Virdi HK et al. ,  2013 
3 6  
 Investigated the association between hematological parameters 
and the severity of chronic per iodontitis in a clinical  trial  that involved 
80 systemically healthy individuals and divided into 2 groups based on 
gingival findings 40 subjects (20 male and 20 female) with moderate to 
severe chronic periodontitis as test  groups and other 40 subjects wit h 
clinically healthy gingiva as controls.  The results indicated lower 
levels of Hb and RBC while the ESR value seemed to be higher in test 
group than control hence a positive relationship was observed between 
blood parameters and severity of chronic period ontal  disease.  
 
Liu J et al.,  2013 
3 7  
 Evaluated the changes in the clinical  parameters and the 
prevalence and quantities of 3 major Periodontopathic organisms 
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namely P.gingivalis, A.actinomycetemcomitans  and T. Forsythia in 
subgingival plaque of patients with generalised chronic periodontitis  
and generalised aggressive periodontitis  in response to Phase I therapy.  
The findings concluded that non-surgical periodontal therapy found to 
be effective in the treatment of cl inical symptoms and the 3 major  
periodontal pathogens were controlled after therapy in both groups.  
 
Kalburgi NB  et al.,  2013 
3 8  
 Investigated the clinical parameters and signs of Anemia of 
Chronic disease in chronic periodontitis patients in non -tobacco users, 
smokers and smokeless tobacco users. 90 chronic periodontit is patients 
of which 30 non-tobacco users,  30 smokers and 30 smokeless tobacco 
users in the age group of 36-59 years were included in the study. The 
haemoglobin concentration, total red blood cell  count and Hematocrit 
value were analysed and found to be lower significantly in smokeless 
tobacco users group followed by smokers group and then by non -
tobacco user group. Thus, study indicated that  periodontitis  should be 
considered as chronic disease and together with the effect of ciga rette 
smoking and / or smokeless tobacco might affect the systemic markers 
related to Anemia of chronic disease.  
 
Nair SK  et  al. ,2013 
3 9 
 
The main objective of the study was to investigate the 
relationship between anemia and periodontal disease. A total number of 
60 subjects were taken from both the genders with a mean age of 46 
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years and they were comprised into 3 groups as group I healthy 
subjects, group II gingivitis and group III with periodontitis  (n=20 in 
each group). Periodontal parameters and orthopantamographs were 
taken for all  groups along with 5 ml of venous blood samples collected 
for hematological assessment.  Comparison of hemat ocrit  values (Hb%, 
MCHC%) in periodontitis , gingivitis  and healthy groups resulted in 
lower PCV value in periodontitis than with gingivitis  and healthy 
individuals. Thus, the study provided evidence that like other chronic 
infections periodontitis tend towards anemia.
 
 
Jenebian N  et  al. ,  2013 
4 0  
 Conducted a case-control study to investigate the correlation 
between haematological parameters associated with anemia and 
moderate chronic periodontitis. 60 systemically healthy male were 
enrolled and blood samples were collected of which 30 men were 
diagnosed with moderate chronic per iodontitis.  Hemaological  and 
clinical parameters were assessed. A reduction of MCV, MCH, Hb, 
Hematocrit value, Serum iron (SI) and total iron binding capacity 
(TIBC) factors were observed with increasing gingival index (GI),  
clinical  at tachment level (CAL) and bleeding on probing (BOP). Thus,  
it  was concluded that correlation was observed between some 
haematological parameters associated with anemia and moderate 
chronic periodont itis .  
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Anand PS et al .,  2014 
1  
 Conducted a case-control study to determine whether generalised 
aggressive periodontitis (GAP) is associated with reduced erythrocyte 
counts and reduced hemogloin levels, in 64 patients with GAP and 
compared with 58 periodontally healthy controls.  Hematological  
parameters such as erythrocyte counts, hemoglobin concentration, 
hematocrit and erythrocyte indices and periodontal parameters such as 
(PI, GI, CAL, PD) were recorded. The findings suggested that patients 
with GAP tend to have lower RBC counts and Hb concentration when 
compared to controls.  
 
Patel  MD et al. ,  2014 
2 0  
 The purpose of the randomized controlled double blind study was 
to investigate chronic periodontit is patients for anemic status and 
analyse the effect of  non-surgical therapy on red blood cell parameters 
over a period of 6 month. 100 systemically healthy male patients were 
recruited of which 50 were periodontally healthy and 50 had chronic 
generalised periodontitis.  Clinical and hematological parameters we re 
assessed at baseline and at 6 month after phase I therapy. The results 
suggested that like other chronic condition periodontitis could lead to 
ACD and non-surgical therapy improved the anaemic status in test 
group.  
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Kolte RA et al .,2014 
4 1  
 Aimed to assess and compare the various blood parameters, total  
leukocyte count (TLC), Bleeding t ime (BT) and clott ing time (CT) in 
healthy and chronic periodontitis subjects.  The results stated that 
periodontitis group showed lower RBC level, MCHC concentration an d 
increased TLC compared to healthy individuals and concluded that 
periodontitis might tend toward anemia and a marked leukocytosis due 
to increased circulating neutrophils and lymphocytes were seen.  
 
Shetty MK et al .,2014 
4 2  
 Conducted a case control study to assess the effect  of 
nonsurgical  periodontal  therapy on hemoglobin levels in chronic 
periodontitis  patients. 40 anemic subjects with reduced hemoglobin 
levels (<8 g/dl),  20 were periodontally healthy and 20 with 
periodontitis  were involved. Blood samples were collected before and 
after non-surgical phase,  the study results showed that  there was an 
improvement in hemoglobin level in test  group after therapy hence it  
was concluded that  phase I periodontal treatment helped in the 
improvement of anemic status in periodontitis patients.  
 
Kundu D et al.,  2014 
4 3  
 Undertaken this study to assess the relation between expression 
of ABO blood group  and HLA antigen, defective PMN adhesion & β2 
integrin expression and percentage of CD14 + CD16+  monocytes in C P 
and AgP patients compared with healthy subjects.  The study results 
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summarized that ABO blood groups and HLA phenotypes with 
periodontal  diseases cannot be established. Leukocytic functional 
defects were found in aggressive periodontitis and a statistical ly 
significant percentage of CD14+ CD16 and CD45RA monocytes were 
found in aggressive periodontitis subjects when compared with normal 
control and chronic periodontitis patients.  
 
Chakraborthy S et al.,  2014 
4 4  
 Aimed to investigate the differences in concentrations of serum 
ferritin in patients with and without periodontal disease before and 
after non-surgical  periodontal  therapy and correlated these values with 
clinical variables related with periodontal  disease.  These findings 
concluded that  increased level of serum ferritin in chronic periodontitis  
were found than in controls and post treatment results showed reduced 
serum ferritin levels comparable to normal range or equal to control  
subjects.  
 
Mishra P et al. ,  2014 
4 5  
 Aimed to find the relationship between erythrocyte parameters 
and chronic periodontitis.  A total number of 50 patients were chosen 
for study and all had atleast 30% or more of the teeth with > 4mm 
pocket probing depth and other clinical  and hemotological variables 
were determined. The mean values of hemoglobin and red blood cell  
indices were found to be significantly lower,  while the value of ESR 
was higher in test group compared to control group the result suggested 
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mild anemia. Thus, the study concluded that  a positive relationship w as 
observed between the hemotological  parameters and the severity of 
periodontal disease.  
 
Kaur N et al. ,  2015 
4 6 
 Reviewed to provide an overview of causes,  signs and symptoms 
of different types of anemias with emphasis on the oral manifestations 
and their influence on the treatment plan of dental  health professionals.  
This review concluded that  dental  health professional might be the first  
to recognize the presence of anaemia, thus their role in the diagnosis 
and management of the various types of anemia cannot be 
underestimated.  
 
Joshipura Vet al .,  2015 
4 7  
  The purpose of the review was to highlight the causes and 
therapeutic concepts of aggressive periodontitis which was rapidly 
progressive in nature.  Authors reviewed not only about the clinical , 
microbiological , immunological and genetic aspects of pathogenesis of  
aggressive periodontitis but also the diagnostic criteria of the disease 
and appropriate non-surgical and surgical treatment options. The 
conclusion stated that  aggressive periodontitis affects smaller 
percentage of population that  seemed to be influenced mainly by 
specific microorganism, host  response and genetic predisposition as it  
is aggressive in nature it requires early diagnosis and treatment to 
prevent further loss of periodontium . 
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Santhosh HN et al .,  2015 
4 8  
 Conducted an observational study to estimate various 
hematologic parameters suggestive of Anemia of Chronic disease in 
patients with chronic periodontitis . 40 patients were selected and 
categorized into cases and controls bas ed on the presence and absence 
of chronic periodontitis.  Complete hemogram, hematocrit,  ESR and 
estimation of serum ferritin levels were done. The results showed 
significant difference in number of neutrophils, ESR, RBC and serum 
ferritin value in subjects  with severe generalised chronic periodontit is  
compared to periodontally healthy patients. Thus, it  was concluded that  
chronic generalised periodontitis by means of an inflammatory process 
might lead to ACD.  
 
Khan NS et al .,  2015 
4 9  
 Conducted a case-control  study to assess the red blood cell  
parameters for signs of anemia in patients with mild, moderate and 
severe chronic periodontitis.  80 healthy male patients were divided into 
four groups based on periodontal  findings as group I con trols 
(clinically healthy periodontium), group II with mild periodontitis , 
group III with moderate chronic periodontitis and group IV with severe 
chronic periodontitis. Laboratory blood investigations viz total  RBC, 
Hb concentration, PCV, MCV, MCH, MCHC were analysed. The 
obtained result showed a statistically significant decrease in RBC with 
increase grades of periodontitis. Thus the substantial  decrease in RBC 
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with increase in severity of periodontal destruction concluded that  
anemia is linked with periodontitis.  
 
Mupalla C et al .,  2016 
6  
 Evaluated and compared the systemic markers related to anemia 
in peripheral  blood of patients with chronic generalised severe 
periodontitis and healthy controls.  60 systemically healthy males were 
divided into 2 groups based on their periodontal status as group A 
(controls) healthy gingiva and group B (test group) chronic generalized 
severe periodontit is.  Periodontal  and hematological parameters were 
recorded in both the groups. The investigation resulted in reduced 
RBC, Hb, and PCV values in group B when compared to group A 
indicating that severe periodontitis has a definite systemic effects.  
 
Anumolu H  et al. ,  2016 
5 0  
 Evaluated the relationship between Anemia and Periodontitis by 
estimating blood parameters.  Clinical  and hematological  parameters 
were evaluated in 50 healthy, 50 chronic generalized periodontit is 
patients.  The results revealed a decrease in Hb and RBC values and 
increase in WBC counts in periodontit is group than in healthy and 
gingivitis group. And it was concluded that  after periodontal therapy 
there was an improvement in Hematocrit  and other blood parameters in 
periodontitis patients with anemia.  
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MATERIALS AND METHODS 
  
 An interventional study was conducted at the Department of 
Periodontology, Adhiparasakthi  Dental  College and Hospital , 
Melmaruvathur. A total  number of 30 subjects were enrolled in the 
study with the age range of 18 -40 years from the outpatient division of 
APDCH. Ethical clearance for the study was obtained from 
Insti tutional Review board (Reference No.2015 -MD-Br II-  VID-05/ 
APDCH).  
 
 All subjects participating in the study were informed about the 
nature of the study and all indivi duals signed in the written informed 
consent form. Clinical and blood parameters were measured at  
baseline, out of 30 patients ,  17 patients met  the inclusion criteria  
(serum ferritin above 30ng / dl) and these  17 patients were allocated 
for Non- surgical  periodontal therapy (NSPT), two patients failed to 
report for NSPT. So, total 15 patients were considered for further 
investigation.  
 
METHOD: 
Group A: 15 subjects (Generalised Aggressive Periodontit is, before 
phase I therapy)  
Group B: 15 subjects (Generalised Aggressive Periodontitis, after 
phase I therapy)  
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INCLUSION CRITERIA: 
 Patients in the age group of 18 -40 years  
 Probing depth and clinical attachment level of ≥5mm  
 Individuals were included in the study if  they had a probing 
depth and a clinical  attachment level of ≥ 5 mm on at least  eight 
permanent teeth,  of which at  least  three were not permanent ﬁrst 
molars or incisors.  (Classiﬁcation of Periodontal Diseases and 
Conditions in 1999)  
 Serum ferritin >30ng/dl.  
 
EXCLUSION CRITERIA: 
 Pregnant women.  
 Lactating women.  
 Individuals with history of any systemic disease.  
 History of any antibiotic therapy or under periodontal treatment  
during 12 month period before the examination.  
 Smokers.  
 Iron deficiency anemia.  
 
Following clinical index and periodontal parameters were recorded 
before and after Phase I therapy:  
 Plaque index (Silness and Loe, 1964)  
 Bleeding index (Ainamo and Bay)  
 Probing pocket depth  
 Clinical  at tachment level.  
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Following Red Blood cell parameters we re analysed before and 
after phase I therapy:  
 Haemoglobin concentration  
 Total Red blood cell counts (RBC)  
 Packed cell volume (PCV)/Haematocrit  (HCT)  
 Erythrocyte sedimentation rate (ESR)  
 Blood indices (MCV, MCH,MCHC)  
 Serum ferritin  
 
METHODS TO BE FOLLOWED: 
 Consecutively,  patients diagnosed with generalized aggressive 
periodontitis who reported to the Department of Periodontics and 
expressed willingness to participate in the study were recruited. Before 
undergoing the examination , a written informed consent  was obtained 
from all  the prospective study participants  and they were subjected to 
the measurement of clinical  index that  includes plaque index and 
gingival bleeding index and clinical parameters including probing 
pocket depth and clinical  attachment level at baseline and after 3 
month post operatively.  
 
BLOOD SAMPLE COLLECTION AND STORAGE:  
 After skin preparation, venous blood samples were obtained by 
vene puncture from the ante-cubital fossa under aseptic condition. 
After placement of a tourniquet, 5  ml of blood was collected using a 
disposable syringe from the median cubital  vein in the antecubital 
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fossa. The 2.5 ml of collected blood sample was  transferred into a plain 
vaccutainer tube for estimation of serum Ferritin levels,  and the 
remaining blood sample was equally transferred into EDTA containing 
vial and sodium citrate containing vial. The blood samples transferred 
into sodium citrate containing vial was assigned to determine ESR 
whilst the blood samples collected in EDTA vial  was used for 
estimation of  hematological variables like (Hb %, RBC count, PCVand 
Blood indices).  
 
PLAQUE INDEX :  (Silness and Löe 1964)  
5 1  
 Plaque index was described by Silness J.  and Loe H. in 1964 and 
fully described by Loe H. in 1967.  
 
SCORING CRITERIA FOR THE PLAQUE INDEX SYSTEM 
 0 = No plaque.  
 1 = A layer of plaque adhering to the free gingival margin and 
adjacent tooth surface. The plaque is not visible to naked eyes, can be 
recognised only by running the explorer around the tooth surface  
2 = Moderately  accumulated soft deposits within the pocket,  margin of 
the gingiva and/or adjacent tooth surface that  is seen by the naked eye.  
3 = Abundance of soft matter seen within the gingival pocket and/or on 
the gingival margin and the adjacent tooth surface.  
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CALCULATION: 
 Plaque index for per tooth= sum of total score from 4 areas of 
the tooth and divided by 4.  
 
 Plaque index for an individual= total plaque indices for al l teeth 
are added and divided by total  No.of teeth examined.  
 
INTERPRETATION:  
SCORE 0:Excellent oral  hygiene 
SCORE0.1 to 0.9:Good oral hygiene  
SCORE 1.0 to 1.9: Fair Oral Hygiene  
SCORE 2.0 to 3.0:  Poor oral  hygiene  
 
GINIGVAL BLEEDING INDEX :
5 2  
 The Gingival Bleeding index (GBI) of Ainamo and Bay  was 
developed as an easy and suitable method for the examiner to assess a 
patient’s progress in plaque control. The presence or absence of 
gingival bleeding can be determined by using a periodontal  probe and 
gently probing the gingival crevice. The appear ance of bleeding within 
10 seconds indicates a positive score, which can be expressed as a 
percentage of the total number of gingival margins examined.  
 
PROBING POCKET DEPTH :
5 2  
 Probing depth is  a measurement of the depth of a sulcus or 
periodontal pocket.  Pocket depth  refers to the distance from the 
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gingival margin to the base of the clinical pocket .  Mesial and distal  
pockets are measured from the buccal aspect and as close as possible to 
the contact points.  Facial and oral pockets were measured at the 
midline of the roots.  Buccal and lingual pockets of multi -rooted teeth 
were measured at the mesial roots in order to avoid the furcation areas. 
Probing involves "stepping" a calibrated periodontal probe (UNC -15) 
around the tooth and recording the deepest poin t at each of six surfaces 
of the tooth: distofacial, facial , mesiofacial, distolingual, lingual,  and 
mesiolingual. A probe reading that falls  between two calibrated marks 
on the probe should be rounded upward to the next highest millimetre. 
Out of 6 surfaces per tooth, the highest probing depth value is taken as 
the probing depth of that  individual tooth.     
 
CLINICAL ATTACHEMENT LEVEL:
5 2  
 Level of attachment  refers to the distance between the base of  
the pocket and CEJ .  The loss of attachment was assessed on the same 
surfaces of the same teeth and with the same probe as used for 
measuring the pocket depth. Following CEJ recognition, the distance 
from the gingival margin to the CEJ was measured. When the CEJ was 
located apical to the gingival margin, the loss of attachment would be 
the difference between the previously recorded depth of the pocket (A) 
and the distance (B) from the gingival margin to the CEJ: (A –B = loss 
of attachment).  In cases where the marginal gingiva  had been subject  to 
recession and the CEJ was exposed, the loss of attachment equalled the 
sum of the pocket depth and the distance from the gingival margin to  
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the CEJ: A + B = loss of attachment. Pocket depth or loss of 
attachment of 1 mm or less was recorded as 1 mm, measurements 
exceeding 1 mm, but less than 2mm, were recorded as 2 mm.  
 
HEMATOLOGICAL VARIABLES :
(5 3 ,  5 4 ,  5 5 )  
 HEMOGLOBIN is the iron-containing oxygen-transport  
metalloprotein in the red blood cells. The average hemoglobin content 
in blood is 11 to 16.38 g/dl .  The value differs according to age and 
gender of an individual. At birth it is increased25 g/dl.  In adult males 
it  is 16 g/dl . In adult  females it  is 14 g/dl .  
 
RED BLOOD CELL COUNT:  RBCs or Erythrocytes are the non -
nucleated formed elements in the blood. They are called as Red blood 
cells because of the presence of colouring pigment called hemoglobin. 
Normal value ranges from 4 to 5.5 mill ions /cu mm  of the blood. In 
adult males,  it  ranges 5.4millions /  cu mm and in adult  females it  is  
4.8mill ions / cu mm.  
 
ERYTHROCYTE SEDIMENTATION RATE (ESR) :  It  is the rate at  
which the erythrocytes settle down, if  a column of anti -coagulated 
blood sample is  allowed to stand on a vertical  tube, the RBCs begin to 
settle down due to gravity with a supernatant layer of clear plasma. 
ESR tends to be increased in women with increasing in age and during 
pregnancy. When there is an increase in fibrinogen, immunoglobulins 
or acute phase reactants the RBCs cluster together to form rouleux  and 
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settle down faster.  It  will be increased in infections,  malignancies and 
chronic disease states like Rheumatoid arthritis. It will be decreased in 
polycythemia, hyperviscosity etc. Two different methods to determine 
ESR are Westergren method and Wintrobe method. Values for E SR 
vary in both the methods because of differences in the tube length and 
shape. It  is  not a diagnostic test  but can be taken as a prognostic one 
that  helps to monitor the progress of an inflammatory disease.   
 
WESTERGREN METHOD: (Normal value)  
Men it is up to 15 mm/hour  
Women it is up to 20 mm / hour.  
WINTROBE METHOD: 
Males:  0-9 mm per hour  
Females: 0-15 mm per hour.  
 
HEMATOCRIT: (PACKED CELL VOLUME)  
 The hematocrit  is  the  fraction of the blood that  composed of red 
blood cells, as measured by centrifuging  blood in a ‘Hematocrit tube’ 
until the cells become tightly packed in the bottom of the tube. The 
proportion of the blood that  is  Erythrocytes (RBC) is called the 
Hematocrit .  If the Hematocrit is 40 then 40% of the blood volume is 
cells and the remainder is plasma. In severe anemia PCV may fall as 
low as 0.10. Conversely,  in some conditions where there is excessive 
production of RBCs resulting in polycythemia, the haematocrit can rise 
to 65%. 
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NORMAL VALUE OF PCV:  
Adult  Men: 47 Adult  Women: 42 
 
BLOOD INDICES: 
 Blood indices are the calculations derived from RBC count, 
haemoglobin content of blood and PCV; it helps in diagnosis of the 
type of anemia.  
 
MCV: It is  the average volume of a single RBC and it  is expressed in 
cubic microns. Normal MCV is  87 cu μ (77 to 93 cu μ)  i f MCV is 
normal the RBC is called Normocytic, if cells with MCV is greater 
than 95 fL is  known as Macrocytic and cells with MCVless than 82fL 
are called as Microcytes.  
MCV =Hct*10/ RBC (10
6  /μl)  
 
MCH:  It  is the quantity or amount of hemoglobin present in one RBC. 
It  is expressed in Picograms. Normal value of MCH is  30 pg (27 to 
32pg).  
MCH = Hb *10/RBC (10
6  /μl)  
 
MCHC: Concentration of Hemoglobin in one RBC. It is the amount of 
hemoglobin expressed in relation to the volume of one RBC. It  is 
expressed in percentage. Normal value is 34 (30 to 35 g/dl).  Normal 
MCHC then the RBC is Normochromic, cells with MCHC less than 
(<25 g/dl) are called as hypochromic. A single RBC cannot be 
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hyperchromic because the amount of hemoglobin cannot increase 
beyond normal.   
MCHC = Hb*100/Hct  
 
SERUM FERRITIN: 
 Ferritin is the most common type of iron storage in the human 
body. Ferritin molecules can be found in the cytoplasm of the 
reticuloendothelial system specifically in the liver and spleen. Iron is 
situated in the center of the molecule in the form of ferric 
hydroxyphosphate, this may contain as many as 4,500 iron atoms. The 
drop in serum ferritin levels can indicate an iron deficiency. The level 
of serum ferritin acts as an indicator of the quantities of iron in the 
human body.  
 
PROCEDURE: 
 VIDAS
®
 ferritin is  an automated quantitative test  for the 
determination of serum ferritin using the  ELFA (Enzyme Linked 
Fluorescent Assay) technique.  
 
PRINCIPLE: 
 The principle is based on one -step enzyme immunoassay 
sandwich method with a final fluorescent detection (ELFA). The Solid 
Phase Receptacle (SPR
®
) serves as the solid phase and as the pipetting 
device for the assay.  The assay reagents are ready-to-use and are pre-
dispensed in the sealed reagent strips.  The steps of the assay are 
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performed by the machine automatically. The reaction medium is 
cycled in and out of the SPR several times. At the final detection step, 
the substrate (4-Methyl-umbelliferyl  phosphate) is cycled in and out of 
the SPR. The conjugate enzyme catalyzes the hydrolysis of this 
substrate into a fluorescent product (4 -methyl-umbelliferone) the 
fluorescence of which is measured at 450 nm. The intensity of the 
fluorescence is proportional to the concentration of antigens present in 
the sample. The final step of assay results are calculated by the 
instrument automatically in relation to the calibration curve that  is  
stored in the memory, and printed results can be obtained.  
 
PROCEDURE FOR ESR: 
 An ESR test  is  also called as SedRate test that  measures the 
speed at which red blood cells sett le at  the bottom of an upright test 
tube. It  is  important because when the presence of abnormal proteins 
are found in the blood, mainly because of inflammation or infection, 
they cause red blood cells to clump together and sink faster.  A 
disposable ESR pipette is  used for performing WESTERGREN’S ESR 
determinations directly in a 12 * 75 mm blood collection tube or 
vaccutainer tubes.  
 
 Procedure is done using QUALES (single use ESR pipettes). 
Collect  1.6 ml of blood in 0.4 ml of sodium citrate 3.8% solution. 
Gently mix the blood, and insert the lower end of  pipette bearing 
vaccum plug into the blood collection tube and using continuous force,  
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push the pipette down to the bottom of the blood collection tube. The 
blood will raise automatically into the pipette and stop at  the zero 
mark. Place the assembly (Tube + Pipette) absolutely vertical on a 
suitable stand and allow the blood cells to sediment without disturbing 
it for 60 mins. After 60 minutes the numerical results can be read in 
millimetres directly from the imprinted scale visible on the pipette.  
 
FULLY AUTOMATED HEMATOLOGY ANALYSER 
 The estimation of RBC count, Hemoglobin concentration, Packed 
cell volume (PCV) / Hematocrit (HCT), and Blood indices (MCV, 
MCH, MCHC) are done using Fully Automated Hematology Analyser 
(GB-325 Genuine Biosystem).  
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Basic Armamentarium: 
1.  Mouth mirror  
2.  UNC 15 probe 
3.  Tweezers  
4.  Universal curettes - 2R/2L & 4R/4L 
5.  Gracey curettes- #1-14 
6.  Surgical gloves  
7.  Mouth masks  
8.  Cotton rolls  
9.  EDTA containing vial,  sodium citrate containing vial and plain 
vacutainer tube 
10.2 ml and 5 ml syringe 
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FIGURE 1: ARMAMENTARIUM 
 
 
FIGURE 2 : PRE-OPERATIVE 
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FIGURE 3 : PROBING DEPTH (BASELINE)  
 
FIGURE 4 : ORTHOPANTAMOGRAPH (Pre-operative)  
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FIGURE 5 : POST-OPERATIVE 
 
FIGURE 6 : PROBING DEPTH (3
rd
 MONTH) 
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FIGURE 7 : COLLECTION OF BLOOD 
 
 
FIGURE 8 : COLLECTED BLOOD SAMPLES 
 
 
 
 
 
Materials and Methods 
 
60 
 
FIGURE 9 : FULLY AUTOMATED HEMATOLOGY ANALYSER 
 
 
FIGURE 10 : CENTRIFUGED SERUM 
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Figure 11 : VIDAS 
®
 FERRITIN 
 
 
FIGURE 12 : ESR - WESTERGREN TUBE 
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RESULTS  
  
 The study was conducted to evaluate the effect  of Non -surgical 
periodontal therapy on Red blood cell parameters of Generalized 
Aggressive Periodontitis patients. A total number of 30 patients 
diagnosed with Generalized Aggressive Periodontitis  were selected 
from outpatient section of Department of Periodontics, Adhiparasakthi 
Dental College and Hospital, Melmaruvathur, Tamil Nadu. All clinical 
parameters were measured at  baseline and blood samples were 
collected and sent for estimation of Red bl ood cell parameters along 
with serum ferritin.  Seventeen Patients with Serum ferritin levels 
above 30 ng/ml were included in the study for further analysis of 
hematological parameters and clinical parameters after phase I therapy 
at the end of third month.  Two patients dropped out during phase I 
therapy. Total No of 15 patients were considered finally for further  
treatment and investigation. The obtained results were tabulated and 
the collected data were subjected to statistical analysis.  
 
STATISTICAL ANALYSIS: 
 The collected data were analysed statistically through (SPSS) 
Statist ical Package for Social  Science).  
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 The Normality tests Kolmogorov -Smirnov and Shapiro-Wilks 
tests results revealed that except variable  ESR (1/2 hour and 1 hour)  
values, all other variables follow Normal distribution, and ESR values 
do NOT follow Normal distribution. Therefore to analyse the data both 
Parametric and Non parametric methods were applied. For variables 
which follow Normal distribution,  to compare mean values between Pre 
Op and Post Op Paired samples t-test  was applied. To compare Pre Op 
and Post  Op ESR values Wilcoxon Signed Rank test  was applied. To 
analyse the data SPSS (IBM SPSS Statistics for Windows, Version 
22.0, Armonk, NY: IBM Corp. Released 2013) was used . Significance 
level was fixed as 5% (α = 0.05).  
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TABLE 1: MEAN CHANGE IN PLAQUE INDEX  SCORES FROM 
BASELINE TO POST OPERATIVE:  
Variable  N Mean Std. Dev t-Value P-Value 
PLAQUE 
INDEX 
Plaque Index: Pre Op 15 1.03760 .068172 
4.085 .001 Plaque Index: Post 
Op 
15 .9673 .03751 
 
 The mean plaque index score at baseline was (1.04  ± .06) and 
post-operative score was found to be (.97 ± .03). On comparing 
baseline score with post -operative score the reduction in the plaque 
index score was found to be statistically s ignificant [P-Value<0 .001] .  
 
CHART 1: MEAN CHANGE IN PLAQUE INDEX SCORES FROM 
BASELINE TO POST-OPERATIVE 
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TABLE 2: THE MEAN CHANGE IN PERCENTAGE OF 
BLEEDING SITES FROM BASELINE TO POST OPERATIVE  
Variable  N Mean Std. Dev t-Value P-Value 
BLEEDING 
INDEX (%) 
Bleeding Index: Pre 
Op 
15 71.2513 19.05725 
11.485 <0.001 
Bleeding Index: Post  
Op 
15 42.7873 18.13282 
 
 The mean bleeding sites at  baseline was (71.25 ± 19.05 %) and  
post-operatively it  was found to be (42.79 ± 18.13%) the reduction in 
bleeding sites  percentage  was found to be Statistically  Signif icant [P- 
Value <0.001]  
 
CHART 2: MEAN CHANGE IN THE PERCENTAGE  OF 
BLEEDING SITES FROM BASELINE TO POST -OPERATIVE 
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TABLE 3: THE MEAN CHANGE IN PROBING DEPTH AND 
CLINICAL ATTACHMENT LEVEL FROM BASELINE TO POST-
OPERATIVE  
Variables   N 
Mean 
(mm) 
Std. Dev t-Value P-Value 
Probing 
Depth: 
Baseline 15 4.79993 .553551 
13.344 <0.001 
Post Op 15 3.74373 .614341 
Clinical 
Attachment 
Level:  
Baseline 15 5.11673 .562817 
15.849 <0.001 
Post Op 15 3.97827 .609834 
 
 The mean probing depth and CAL at baseline was (4.79 ± .55 
mm) and (5.12 ± .56 mm), after phase I therapy the probing depth and 
clinical attachment level was found to be  (3.74 ± .61 mm) and (3.98 ± 
.60 mm) respectively.  On comparing baseline probing depth and 
clinical  attachment levels  with post-operative probing depth and 
clinical attachment level the reduction in Probing depth and gain in 
Clinical attachment level post -operatively was found to be statistically 
significant with [P-value  <0.001]  
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CHART 3: THE MEAN CHANGE IN PROBING DEPTH FROM 
BASELINE TO POST-OPERATIVE 
 
 
CHART 4: THE MEAN CHANGE IN CLINICAL ATTACHMENT 
LEVEL FROM BASELINE TO POST-OPERATIVE 
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TABLE 4: MEAN CHANGE IN RBC COUNTS FROM BASELINE 
TO POST-OPERATIVE. 
Variable  N Mean Std. Dev t-Value P-Value 
Red Blood Cell 
count  
(million/cu mm) 
Pre Op 15 4.4753 .54086 
4.610 <0.001 
Post Op 15 4.9787 .61752 
 
 The mean RBC value at  baseline was (4.48 ± .54)  millions/cu 
mm and post-operative value was (4.98 ± .61)  millions/cu mm. On 
comparing both the values, the increase in RBC count post -operatively 
was found to be statistically significant with [ P-value <0.001]  
 
CHART 5: MEAN CHANGE IN RBC COUNT FROM BASELINE 
TO POST-OPERATIVE 
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TABLE 5: THE MEAN CHANGE IN HEMOGLOBIN COUNTS 
FROM BASELINE TO POST-OPERATIVE 
Variable  N Mean Std. Dev t-Value P-Value 
Haemoglobin 
(Percentage)  
Pre Op 15 12.7327 1.22915 
4.740 <0.001 
Post Op 15 14.0480 1.30395 
 
 The mean hemoglobin concentration at  baseline (12.73 ± 1.22 %) 
and post-operatively was (14.04 ± 1.30 %). On comparing both values 
the increase in Hb concentration post -operatively was statistically 
significant with [P-value <0.001]  
 
CHART 6: MEAN CHANGE IN HEMOGLOBIN CONCENTRATION 
FROM BASELINE TO POST-OPERATIVE 
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TABLE 6: MEAN CHANGE IN MCV VALUE FROM BASELINE 
TO POST- OPERATIVE 
Variables   N Mean Std. Dev t-Value P-Value 
MCV (fL)  
Pre Op 15 87.70 10.69 
.571 .572 
Post Op 15 89.69 8.23 
 
 The mean change in MCV value from baseline to post-therapy 
was (87.70 ± 10.69  to 89.69 ± 8.23 fL) the increment in the post -
operative value was not  found to be statistically significant.  
 
CHART 7: MEAN CHANGE IN MCV VALUE FROM BASELINE 
TO POST-TREATMENT:  
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TABLE 7: MEAN CHANGE IN MCH VALUE FROM BASELINE 
TO POST- OPERATIVE 
Variables   N Mean Std. Dev t-Value P-Value 
MCH (pg) 
Pre Op 15 28.27 2.07 
-.536 .601 
Post Op 15 28.63 1.28 
 
 The mean change in MCH value from baseline to post -treatment 
was (28.27 ± 2.07 to 28.63 ± 1.28  pg) the increase in postoperative 
value was not significant stat istically.  
 
CHART 8: MEAN CHANGE IN MCH VALUE FROM BASELINE 
TO POST-TREATMENT: 
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TABLE 8 : MEAN CHANGE IN MCHC VALUE FROM BASELINE 
TO POST-OPERATIVE 
Variable  N Mean Std. Dev t-Value P-Value 
MCHC (%) 
Pre Op 15 29.99 5.32 
.530 .600 
Post Op 15 30.89 3.86 
 
 The mean change in MCHC value from baseline to post -therapy 
was (29.99 ± 5.32 to 30.89 ± 3.86 %) the increase was not found to be 
statistically significant.  
 
CHART 9: MEAN CHANGE IN MCHC VALUE FROM BASELINE 
TO POST-TREATMENT 
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TABLE 9 : THE MEAN CHANGE IN PCV (PACKED CELL 
VOLUME) FROM BASELINE TO POST -OPERATIVE 
Variables   N Mean 
Std. 
Dev 
t-
Value 
P-
Value 
PCV / Hematocrit 
volume (%) 
Pre Op 15 44.820 8.2487 
-1.000 .334 
Post Op 15 47.693 8.5280 
 
 The mean PCV percentage at baseline was (44.82 ± 8.25 %) and 
post-operatively (47.69 ± 8.53 %) respectively.  On comparing these 
two mean values the increase in PCV percentage after therapy was  not 
statistically significant with P-value .334.  
 
CHART 10: THE MEAN CHANGE IN PCV PERCENTAGE FROM 
BASELINE TO 3 MONTH POST-OPERATIVE 
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TABLE 10: THE MEAN CHANGE IN ESR VALUE FROM 
BASELINE TO POSTOPERATIVE AFTER HALF-AN HOUR AND 
ONE HOUR INTERVAL 
 
Descriptive Statistics  
 Pre Op Post Op 
ESR (1/2hr)  
N 15 15 
Mean 8.47 4.07 
Std. Dev 6.010 2.549 
Median 7.0 3.0 
1st Quartile  3.0 2.0 
3rd Quartile  12.0 6.0 
ESR(1hr)  
N 15 15 
Mean 20.87 10.80 
Std. Dev 13.266 7.173 
Median 16.0 9.0 
1st Quartile  9.0 5.0 
3rd Quartile  36.0 18.0 
 
Wilcoxon Signed Ranks Test to compare ESR values between Pre -
Operative and Post-Operative values:  
 P-Value 
ESR (1/2hour): Post Op - 
ESR(1/2hour):  Pre Op 
Negative Ranks  
0.001 
Positive Ranks  
ESR(1 hour): Post Op - 
ESR(1hour): Pre Op 
Negative Ranks  
0.001 
Positive Ranks 
 
Results 
 
75 
 
 The mean baseline ESR value at half -an hour was (8.47 ± 6.01) 
and post-operatively it  was (4.07 ± 2.55),  On comparing  these two 
mean values the decrease in ESR value was found to be statistically  
significant with P-value <0.001.  
 
 The mean baseline ESR value at  one hour was (20.87 ± 13.26) 
and post-operatively it  was (10.80 ± 7.17),  On comparing these values 
the decrease in ESR value post -therapy was found to be statistically  
significant with P-value <0.001.  
 
CHART 11: THE MEAN CHANGE IN ESR VALUE AT HALF AN 
HOUR FROM BASELINE TO POST-TREATMENT 
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CHART 12: THE MEAN CHANGE IN ESR VALUE AT ONE HOUR 
FROM BASELINE TO POST-TREATMENT 
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DISCUSSION 
 
 An interventional study was conducted in Department of 
Periodontology, APDCH, Melmaruvathur, Tamilnadu. 30 Generalized 
Aggressive Periodontitis patients were enrolled in the study.  A written 
informed consent was obtained from all the patients. Hematological  
parameters like (RBCs, Hb, PCV, ESR and Serum Ferri tin) were 
evaluated at  baseline along with the clinical  indices (Plaque index, 
Bleeding index) and clinical  parameters (Probing depth,  Clinical  
attachment level). Among the thirty GAgP patients ,  thirteen patients 
had their serum ferri tin levels less than 30 ng/ ml, which were found to 
be a positive indication of Iron deficiency. Seventeen Patients with 
serum ferritin above 30 ng /ml and Hb less than or equal to 15% were 
included in the study to evaluate the effect of periodontal  therapy on 
Red blood cell parameter. All participants were allocated for Non -
surgical periodontal  therapy and further blood investigation and 
clinical parameters at the end of third month post operatively.  Two  
patients failed to report , finally 15 patients were considered in the 
study.  
 
 The relationship between Anemia and Periodontal disease was 
explored in 20
t h
 century. Several  studies reported the concept of 
Anemia as an etiologic factor for periodontitis  an d periodontitis as a 
risk factor for anaemia. Several studies confirmed the link between 
Anemia and Chronic Periodontitis  (Hutter et al .,  Gokhale et al.,  Naik 
et al. ,  Pradeep et al.,  and Patel et al .,) .Few studies also suggested 
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that periodontal therapy helps to reduce inflammation thereby 
improving anemic status in periodontitis patients (Anumolu et al.,  
Shetty et al .,  Agarwal et al .,  Pradeep et al.,).  
 
 The evidence for the relationship between AgP and Anemia is 
limited. Anandh et al.,  in his case-control study suggested that like 
chronic periodontitis, GAgP also associated with a risk for Anemia. 
Christan et al. ,  conducted a prospective longitudinal study to examine 
the systemic effect  of non-surgical therapy on WBC count and 
differential  blood count in GAgP patients and concluded that 
periodontal  therapy may significantly reduce leucocyte counts in 
patients with GAgP but reported mild difference between smokers and 
non-smokers.  
 
 This is the first intervention study conducted to evaluate the 
systemic markers related to anemia in GAgP patients before and after 
phase I periodontal therapy. Since aggressive periodontitis is presented 
with higher levels of circulating cytokines such as IL -1, IL-6, IL-17, 
TNF-α , INF-γ and other pro -inflammatory cytokines, which might also 
lead to a low grade systemic inflammation that  would cause Anemia. In 
order to treat  ACD, i t’s better to eliminate the cause either systemic or 
local thereby minimizing the treatment from invasive to cons ervative.  
Untreated anemia may cause a critical issue in patient s with chronic 
disease
5 6
.  In case of inflammatory disease like Periodontitis , 
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periodontal therapy is one such possible way to control the 
inflammation and reverse the condition.  
 
 Hence, the present study was conducted to investigate whether 
Aggressive periodontitis is  associated with reduced Erythrocyte count 
and Hemoglobin levels, and like chronic periodontitis  Aggressive 
periodontitis also respond to Phase I periodontal  therapy.  
 
 The study results  showed a significant reduction in the mean 
Plaque Index score from baseline to post -therapy (1.03 ± .06 to .96 ± 
.03). This may be due to the elimination of local  factors which harbors 
numerous pathogens.  There was a statistically significant reduction in  
the mean Bleeding sites percentage from baseline to post -therapy 
following Non-surgical phase (71.25 ± 19.05% to 42.79 ±1.13%). This 
may be due to the resolution of inflammation. Periodontal 
inflammation often causes bleeding from the gingiva, direct loss  of 
blood from the gingiva might also be a reason for reduced RBC count  
but evidence has not been substantiated, few plausible mechanisms 
explained the decreased hematological  parameters in periodontitis  
patients
3 0 ,3 4
.  So the reduction in bleeding sites  post-operatively would 
have improved the hematological variables. There was a significant 
reduction in the mean probing depth readings from baseline to 3 
months after therapy (4.80 ± .55 mm to 3.74 ± .61 mm) . In case of 
increased probing pocket depth the subgingival organism and their 
products enter the blood stream and affect the distant sites through 
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ulceration of pocket epithelium that  evoke low grade systemic 
inflammation, that have been related to suppre ssion of erythropoiesis.
8
 
The reduction in probing depth post -therapy could be attributed to 
effective mechanical  debridement as a result of which bacterial  load 
and inflammation reduced. A significant gain in mean CAL value was 
seen from baseline to 3 months after therapy (5.12 ± .56 mm to 3.98 ± 
.60 mm) which might be due to subgingival scaling and root planing as 
it  leads to resolution of inflammation and cessation of disease 
progression hence resulting in gain of attachment level.  Following 
phase I therapy all  participants received oral hygiene instruction for 
home care plaque reduction, not only the clinical parameters but also 
the hematological parameters were found to be improved from baseline 
to post-therapy.  
 
 The blood investigation results showed  a statistically significant 
increase in the mean RBC count from baseline to post -operative  
(4.48 ± .54 to 4.98 ± .61)  millions/cu mm. And the mean Hb change 
from pre-operative to post -operative (12.73 ± 1.22 % to 14.05± 1.30 %) 
which was also statistical ly significant.  The low grade systemic 
inflammatory burden  was suggested as  one of  reason s for defective 
red cell  production in spite of adequate iron stores .  Once the 
elimination of inflammatory components are done the suppression of 
erythropoeisis is prevented thereby improvement in anemic status is  
achieved. The increase in values of HB% and RBC count post treatment 
was supported by many studies done in chronic periodontitis and the 
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results were in accordance with the study done by Malhotra et al . ,  in 
chronic periodontitis  patients. Since there is very few studies done in 
GAgP related to anemia and no interventional study so far was done, 
hence the study results were not compared with any other studies.  
 
 The mean improvement in Haematocrit (PCV) percentage from 
baseline to 3 months post  operatively (44.82 ± 8.25 % to 47.69 ± 
8.53%) was found to be statistically non -significant; this may be due to 
small  sample size.  The increase in the blood indices (MCV, MCH, and 
MCHC) value post treatment was not very high. The mean changes in 
the blood indices values were not statistically significant. The baseline 
blood indices values were between the normal or near normal range 
that indicated the mild anemia was not due to iron or vitamin 
deficiency.  
  
 In general , the reduction in the MCV and MCH value suggests 
microcytosis which is commonly seen in iron deficiency and elevated 
levels of MCV and MCH value suggests macrocytosis caused by 
vitamin deficiency. In this study the MCV and MCH values were in 
normal reference range with small  increment seen post -operatively 
indicating the Anemia to be normocytic as seen in ACD. Even though 
the haemoglobin concentration at  baseline was found to be reduced the 
MCHC was not below the normal reference ranges in both the groups at 
baseline and post -therapy, indicating that Hb concentration per volume 
of packed red cell  is  normal.  The normal MCHC reference range 
indicates normochromic anemia as seen in ACD.  
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  Another valuable parameter indicating the underlying 
inflammatory process was the ESR value.  The elevated ESR value at  
baseline suggested that  Aggressive Periodontitis  has an inflammatory 
component systemically and the reduction in ESR value after 
periodontal therapy over t ime suggested resolution of inflammation and 
inflammatory markers. ESR estimation is the oldest laboratory methods 
that help to monitor disease activity and reflects the systemic response 
of any chronic disease and results  from a change in colloidal state of 
plasma that  could be caused by variation in plasma pro teins globulins 
and fibrinogens.
1
 
  
 Aggressive periodontitis patients have elevated  ESR when 
compared to chronic periodontitis and healthy individuals.  The mean 
change in ESR value at one hour from baseline to post -therapy was 
statistically significant (20.87 ± 13.27  mm to 10.80 ± 7.173 mm). This 
statistically significant reduction of ESR va lue post-therapy might be 
due to the reduction in the systemic disease activity.   
  
 The results indicated that the RBC count and Hb concentration 
were significantly increased after therapy with a significant decrease in 
ESR value and minimal increment was  observed in the PCV, MCH, 
MCV and MCHC. Clinical parameters showed a statistically significant 
improvement after therapy. Few limitations of this present study were 
the relatively smaller sample size and variables like socioeconomic 
status and stress were not elucidated.  
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CONCLUSION  
  
 As the saying goes “Mouth is the mirror of health and disease”.  
The concept that periodontal diseases  are confined to tooth and 
supporting structures has been revised, as it  can exaggerate to cause 
wide ranging systemic effects. Aggressive periodontitis being one of 
the clinical entity that  can cause progressive destruction of 
periodontium and loss of alveola r bone. This might lead to increased 
levels of circulat ing pro-inflammatory cytokines. This low grade 
systemic inflammation might cause depletion of RBC production and 
anaemia to a milder extent when compared to other chronic 
inflammatory disease like rheumatoid arthritis.  
 
 The main aim of the present study was to evaluate the systemic 
markers related to anaemia in GAgP patients before and after phase I 
therapy. The results of this present study showed,  
1)  A statistically significant improvement in the clinic al parameters  
were observed such as reduction in  Plaque index score,  
Percentage of Bleeding sites,  Probing depth and  gain in  Clinical 
attachment level  after Phase I periodontal therapy in GAgP 
patients.  
2)  A statistically significant improvement in Erythrocyte count and 
Haemoglobin concentration  was observed after Non-surgical  
periodontal therapy in GAgP patients.  
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3)  Following Phase I therapy a very minimum increment in the MCH, 
MCV, MCHC  value was observed which was not found to be 
statistically signif icant,  the small  increment in the value 
suggesting Normocyt ic Normochromic Anemia as seen in ACD. 
4)  The improvement in the PCV percentage after non -surgical therapy 
was not found to be statistically significant. This may be due to 
smaller sample size.  
5)  A statistically significant decrease in the Erythrocyte 
Sedimentation Rate  was observed after therapy indicating a 
reduction in the systemic infection.  
 
 Within the limitations of this present study it  can be concluded 
that like other inflammatory disease , Aggressive periodontitis also 
exaggerate a mild systemic inflammation that  might cause ACD and 
like chronic periodontitis,  Generalized Aggressive Periodon titis also 
respond to Non-surgical periodontal therapy and provides evidence in 
the improvement of anemic status.   
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Annexure 
 
i 
 
PROFORMA 
 
EVALUATION OF SYSTEMIC MARKERS RELATED TO ANEMIA 
IN THE PERIPHERAL BLOOD OF GENERALIZED AGGRESSIVE 
PERIODONTITIS PATIENTS BEFORE AND AFTER PHASE I 
PERIODONTAL THERAPY –  AN INTERVENTIONAL STUDY 
 
Name:                                            Age/ Gender:                          
OP.No:                           Date:        
 
Occupation:                                  Address:  
         
Chief complaint :  
 
History of presenting illness:  
 
Past medical history:  
 
Past dental history:  
 
Family  history:  
 
Intra-Oral examination:  
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ii 
 
PERIODONTAL PARAMETERS:  
PLAQUE INDEX: (Silness J.  and Loe H. 1964)  
BASELINE: 
              
17       16     15     14     13     12      11     21      22     23     24     25     26      27 
              
  47     46    45     44     43     42    41     31    32     33    34    35     36     37 
 
SCORE =                         Excellent/Good/Fair/Poor  
 
3
rd
 MONTH: 
              
17       16     15     14     13     12      11     21      22     23     24     25     26      27 
              
  47     46    45     44     43     42    41     31    32     33    34    35     36     37 
 
SCORE =                         Excellent/Good/Fair/Poor  
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GINGIVAL BLEEDING INDEX 
3
rd
 MONTH               
BASELINE               
 7  6  5  4  3  2  1  1  2 3  4  5  6  7  
BASELINE                
3
rd
 MONTH               
 
PROBING DEPTH: 
UPPER ARCH 
 
      LOWER ARCH 
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CAL: 
3
rd
 
MONTH 
              
BASELINE               
 7 6  5  4  3  2  1  1  2 3  4  5  6  7  
BASELINE                
3
rd
 
MONTH 
              
 
DIAGNOSIS:  
 
HEMATOLOGICAL PARAMETERS 
 
INVESTIGATIONS 
RESULTS 
PRE-OP 
(BASELINE) 
POST-OP 
(3
rd  
MONTH) 
RBC COUNT   
HB%   
MCV   
MCH   
MCHV   
PCV   
ESR   
 
 
 
SERUM 
FERRITIN 
 
RESULT 
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TREATMENT 
 
Date Treatment done 
Appointment 
date 
Staff 
signature 
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PARTICIPANT INFORMED CONSENT FORM (PICF)  
(English)  
Protocol / Study number: ______________________  
Participant identification number for this trial: _______________________  
 
 The contents of the information sheet dated that was provided 
have been read carefully by me /  explained in detail  to me, in a 
language that  I comprehend, and I have fully understood the contents.   
I confirm that I have had the opportunity to ask questions.  
 
 The nature and purpose of the study and its potential risks /  
benefits and expected duration of the study, and other relevant details  
of the study have been explained to me in detail.   I understand that  my 
participation is voluntary and that  I am free to withdraw at  any time, 
without giving any reason, without my medical  c are or legal right 
being affected.  
 
 I understand that  the information collected about me from my 
participation in this research and sections of any of my medical notes 
may be looked at  by responsible individuals from APDCH.  I give 
permission for these individuals to have access to my records.  
I agree to take part  in the above study.  
 
------------------ --------------------------        ---------------------------------  
(Signatures /  Left  Thumb Impression)  Signatures  of the Principal Investigator  
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ஆராய்ச்சியில் பங்கேற்பதற்கு இணக்ேம் 
தேதி: 
த ோயோளியின் பெயர்   :   
வயது  / ெோலினம்   :   
புறத ோயோளி எண் : 
அறுவவ சிகிச்வை மருத்துவ நிபுணரின் பெயர் : 
சிகிச்வையின் பெயர் :_____________________ 
அளிக்கப்ெடும் மயக்க மருந்தின் வவக : 
  
எனது ேற்தெோவேய வோய்  லம் குறித்தும், அேற்கு உரிய சிகிச்வை 
முவறகவளயும், மோற்று சிகிச்வை முவறகவளயும் மற்றும் சிகிச்வை தமற்பகோள்ளோவிடில் 
ஏற்ெடும் பின்விவளவுகவளயும் ெல்மருத்துவர் முழுவமயோக என்னிடம் கூறினோர். 
அேற்கோன எனது ைந்தேகங்கவளயும் ெல்மருத்துவரிடம் தகட்டு பேளிவுெடுத்தி 
பகோண்தடன். தமலும் சிகிச்வை முவற, என் சிகிச்வையின் தெோது தேவவப்ெடும் மயக்க 
மருந்துகள் மற்றும் பிற மருந்துகள் பைலுத்ே ைம்மதிக்கின்தறன்.  ோன் மனப்பூர்வமோக 
எனது சிகிச்வை முவற மற்றும் அேனோல் வரும் பின்விவளவுகவளயும் 
ஏற்றுக்பகோள்கிதறன்  மற்றும் மருத்துவர்  கூறும் அறிவுவரகவளயும் கவடபிடிப்தென். 
தமதல பைோல்லப்ெட்டு இருக்கும் ஆரோய்ச்சி ஆய்வில் ெங்தகற்ெேற்கு 
மனப்பூர்வமோன எனது ைம்மேம். 
தமலுள்ள ேகவல்கள் உள்ளிட்டு ஆரோய்ச்சி ஆய்வோனது வோய் வழியோக 
விளக்கப்ெட்டிருக்கிறது மற்றும் ெங்தகற்ெேற்கு சுய விருப்ெத்தில் இ ணங்குகிதறன் 
என்ெது இந்ே ஆவணத்தில் வகபயழுத்திடுவேன் அர்த்ேமோகும். 
 
 
த ோயோளியின் வகபயோப்ெம்  அறுவவ சிகிச்வை நிபுணரின் வகபயோப்ெம் 
 
 
 
